Topiramate 68382-0358-05

Package NDC

68382-0358-05

Manufacturer: Zydus Pharmaceuticals Usa Inc.
Dosage Form: Capsule, Extended Release
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: November 13, 2023
Listing Expires: December 31, 2027
Application: ANDA207382

Need to source Topiramate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Topiramate	200 mg/1

Drug Class

Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 3A4 Inducers [MoA]Decreased Central Nervous System Disorganized Electrical Activity [PE]

Selected Package

68382-0358-05Selected

500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-358-05)

Other packages for this product(3)

68382-0358-01

100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-358-01)

View →

68382-0358-06

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-358-06)

View →

68382-0358-78

3 BLISTER PACK in 1 CARTON (68382-358-78) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (68382-358-30)

View →